Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Current Leases (2022 - 2024)

Spruce Biosciences (SPRB) has disclosed Current Leases for 3 consecutive years, with $267000.0 as the latest value for Q2 2024.

  • On a quarterly basis, Current Leases changed N/A to $267000.0 in Q2 2024 year-over-year; TTM through Jun 2024 was $267000.0, a N/A change, with the full-year FY2023 number at $251000.0, changed N/A from a year prior.
  • Current Leases was $267000.0 for Q2 2024 at Spruce Biosciences, up from $259000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $380000.0 in Q2 2022 to a low of $229000.0 in Q1 2023.
  • A 3-year average of $277200.0 and a median of $259000.0 in 2024 define the central range for Current Leases.
  • Biggest YoY gain for Current Leases was 13.1% in 2024; the steepest drop was 13.1% in 2024.
  • Spruce Biosciences' Current Leases stood at $380000.0 in 2022, then plummeted by 33.95% to $251000.0 in 2023, then rose by 6.37% to $267000.0 in 2024.
  • Per Business Quant, the three most recent readings for SPRB's Current Leases are $267000.0 (Q2 2024), $259000.0 (Q1 2024), and $251000.0 (Q4 2023).